Sir James Whyte Black was a Scottish physician and pharmacologist, born in Uddingston in 1924 and dead in 2010, who shared the 1988 Nobel Prize for Medicine with Gertrude Elion and George Hitchings for pioneering strategies of rational drug design. After graduating in medicine at St Andrews in 1946 and teaching in Singapore and Glasgow, he joined ICI Pharmaceuticals in 1958, where he developed propranolol, a beta blocker for heart disease. Later, at Smith, Kline and French, he developed cimetidine, an H2 receptor antagonist for stomach ulcers, launched as Tagamet in 1975. He held posts at University College London, the Wellcome Research Laboratories and King's College London, founded the James Black Foundation in 1988, and served as chancellor of the University of Dundee.
Facts
PrizeNobel Prize in Physiology or Medicine 2 Connections
In the Other Atlases
Same As
Also in Science Atlas: the same subject.
Nationality
Also in Geography Atlas: the nationality of this subject.
Source James Black (pharmacologist) (Wikipedia)Lead sentence, nationalityQuote, Lead sentence, nationality
was a Scottish physician and pharmacologist
Sources
1. James Black (pharmacologist) (Wikipedia)
Lead sentence, birth date
born (14 June 1924
Lead sentence, death date
Died 22 March 2010)
Lead sentence, nationality
was a Scottish physician and pharmacologist
In Group: Hormone, Vitamin and Drug Discoverers, Lead paragraph
developed propranolol, a beta blocker used for the treatment of heart disease
View the Source2. Nobel Prize Outreach: Nobel Prize API: laureates in Physiology or Medicine, entries 201 to 250
Nobel Prize Outreachlaureate id 437, nobelPrizes
"nobelPrizes": [ { "awardYear": "1988", "category": { "en": "Physiology or Medicine"
laureate id 437, gender
"fullName": { "en": "Sir James W. Black", "se": "Sir James W. Black" }, "fileName": "black", "gender": "male"
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.